Publications
Publications
- July 2023
- HBS Case Collection
HealthVerity: Real World Data and Evidence
By: Satish Tadikonda
Abstract
Andrew Kress (CEO and founder) and his team had built a promising marketplace business at HealthVerity serving its core market in healthcare, with a focus on pharmaceutical R&D and services. Thus far, HealthVerity’s products had been unique to the pharma and pharma services customer segment. However, there was a real opportunity to apply the underlying technology across multiple industries, for which some investors strongly advocated. The company was grappling with questions of whether to increase revenues by expanding to other verticals beyond healthcare or by going deep with its current customer base and providing end-user analytics-based applications on top of their marketplace offerings. The company believed they had a unique understanding of a technically-challenging market in healthcare, and wondered how the model would scale. Kress wondered if there were ways in which the company could focus on specific analytics solutions or end-user applications (and which ones, specifically?), and if so, would that be worth the effort and risk, or did the approach need to be all or nothing? And was he limiting his thinking about the risk and opportunity to enter adjacent markets solely because of lack of familiarity or was there a real chance to serve other customer segments well if better understood and resourced, and how quickly could the company figure out the answer to that question without risking excessive time and capital?
Citation
Tadikonda, Satish. "HealthVerity: Real World Data and Evidence." Harvard Business School Case 824-019, July 2023.